Gendell Jeffrey L’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Gendell Jeffrey L’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.5M	Hold	262,278	–	–	0.37%	29
2026 Q1	$33.5M	Hold	262,278	–	–	0.46%	23
2025 Q4	$32M	Buy	262,278 +30,000	+13%	+$3.44M	0.56%	20
2025 Q3	$23.3M	Buy	232,278 +140,000	+152%	+$12.6M	0.43%	22
2025 Q2	$7.65M	Buy	92,278 +53,432	+138%	+$4.26M	0.2%	24
2025 Q1	$3.15M	Hold	38,846	–	–	0.14%	54
2024 Q4	$3.5M	Hold	38,846	–	–	0.11%	62
2024 Q3	$3.84M	Sell	38,846 -80,454	-67%	-$7.9M	0.12%	56
2024 Q2	$11.1M	Buy	119,300 +20,000	+20%	+$1.79M	0.39%	31
2024 Q1	$9.42M	Buy	+99,300	New	+$9.21M	0.36%	26

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Gendell Jeffrey L's XBI Position: Q2 2026 in Review

Gendell Jeffrey L held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 262,278 shares worth $41.5M. The position accounts for 0.37% of the portfolio, ranked #29.

Gendell Jeffrey L first reported a position in XBI in Q1 2024 and has held it in 10 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Gendell Jeffrey L held 262,278 shares of State Street SPDR S&P Biotech ETF worth $41.5M as of Q2 2026.
Gendell Jeffrey L left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.37% of Gendell Jeffrey L's portfolio in Q2 2026, its #29 holding.
Gendell Jeffrey L first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 10 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Gendell Jeffrey L's 13F filing for Q2 2026, filed 14 Aug 2026.